Atlas Trials

Probiotics as a Novel Approach to Modulate Gut Hormone Secretion and Risk Factors of Type 2 Diabetes and Complications

Clinical trial NCT01250106 · UNKNOWN

Trial details

NCT number
NCT01250106
Sponsor
German Diabetes Center
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
ObesityType 2 Diabetes
Start date
2010-11-01
Primary completion
2011-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.